Xencor (NasdaqGM:XNCR) Earnings Call Presentation

Initial Results from Ongoing Dose -Escalation Study of XmAb819 & Oncology Pipeline Update October 24, 2025 ® Today's Speakers Xencor Management Guest Speaker Bassil Dahiyat, Ph.D. President & Chief Executive Officer Co-director, Kidney Cancer Program City of Hope Comprehensive Cancer Center 2 John Desjarlais, Ph.D. Executive Vice President & Chief Scientific Officer Dane Leone Executive Vice President & Chief Strategy Officer Sumanta Pal, M.D., F.A.S.C.O. Professor, Department of Medical Oncology & Therapeu ...